Construction method of characteristic chromatogram of qi-tonifying and blood-nourishing preparation as well as characteristic chromatogram and application of characteristic chromatogram

The characteristic map of Yiqi Vitiligo preparation was constructed through high-performance liquid chromatography detection method, which solved the problem that it was difficult to fully reflect the active ingredients in the existing technology, achieved efficient quality control of Yiqi Vitiligo preparation, and ensured product stability and uniformity.

CN119000953AActive Publication Date: 2024-11-22GUANGDONG HONGSHANHU PHARM CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411339261.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-25
Publication Date
2024-11-22
Estimated Expiration
2044-09-25

AI Technical Summary

Technical Problem

The prior art is difficult to fully reflect the characteristic map of the active ingredients in Qi-invigorating and blood-revitalizing preparations, resulting in difficulty in quality control.

Method used

Using high-performance liquid chromatography detection method, a characteristic map of Yiqi Vitiligo preparation was constructed through a combination of gradient elution procedures and specific mobile phases, including the optimization of extraction solvents and chromatographic detection conditions, the characteristic peaks were determined and the control characteristic map was constructed.

Benefits of technology

Good quality control of the stability, precision and repeatability of Qi and blood vitamin preparations is achieved, ensuring the uniformity and stability of the product, and improving the overall quality control level.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005059214670000081
    Figure BDA0005059214670000081
  • Figure BDA0005059214670000091
    Figure BDA0005059214670000091
  • Figure BDA0005059214670000101
    Figure BDA0005059214670000101
Patent Text Reader

Abstract

The invention relates to a construction method of a characteristic chromatogram of a qi-tonifying and blood-maintaining preparation as well as the characteristic chromatogram and application of the characteristic chromatogram, and the characteristic chromatogram of the qi-tonifying and blood-maintaining preparation containing a plurality of characteristic peaks is constructed by adopting specific high performance liquid chromatography detection and analysis conditions for the qi-tonifying and blood-maintaining preparation. The construction method of the characteristic chromatogram of the qi-tonifying and blood-nourishing preparation has the advantages of good stability, high precision, good repeatability and the like after methodology verification, and can comprehensively reflect effective components contained in the qi-tonifying and blood-nourishing preparation, so that the quality of the qi-tonifying and blood-nourishing preparation is objectively, comprehensively and accurately evaluated; the method is of great significance in controlling the quality of the qi-tonifying and blood-nourishing preparation and ensuring the clinical curative effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of traditional Chinese medicine detection, and in particular to a method for constructing a characteristic spectrum of a Qi-invigorating and blood-reinforcing preparation, and its characteristic spectrum and application. Background Art

[0002] Yiqiweixue preparations are pure Chinese medicine preparations made from pig blood extract, astragalus and jujube. They have the effect of nourishing blood and replenishing qi. They are mainly used for sallow or pale complexion, dizziness, fatigue, shortness of breath, lazy speech, spontaneous sweating, pale lips and tongue, and weak pulse caused by qi and blood deficiency. Yiqiweixue preparations include Yiqiweixue capsules, Yiqiweixue tablets, Yiqiweixue granules and Yiqiweixue granules (without sucrose addition).

[0003] Yiqiweixue preparations are made of three herbs, and their chemical composition is relatively complex. Quality control is the basis for ensuring the effectiveness of clinical medication. In traditional methods, there are few research reports on Yiqiweixue preparations, and there is a lack of characteristic spectra that fully reflect the effective ingredients contained in Yiqiweixue preparations. The characteristic spectrum of traditional Chinese medicine is a comprehensive and quantifiable identification method that can more comprehensively reflect the types and quantities of chemical components contained in traditional Chinese medicine and its preparations, and then provide an overall description and evaluation of the quality of the medicine. Therefore, it is urgent to provide a detection method for the characteristic spectrum of Yiqiweixue preparations to better control product quality. Summary of the invention

[0004] Based on this, it is necessary to provide a method for constructing a characteristic spectrum of Qi-invigorating and blood-replenishing preparations. The characteristic spectrum of Qi-invigorating and blood-replenishing preparations constructed by this method has multiple characteristic peaks, which can comprehensively reflect the effective ingredients contained in the Qi-invigorating and blood-replenishing preparations, and realize objective, comprehensive and accurate quality control of the Qi-invigorating and blood-replenishing preparations.

[0005] One aspect of the present invention provides a method for constructing a characteristic spectrum of a Qi-invigorating and blood-retaining preparation, comprising the following steps:

[0006] Extract the Yiqiweixue preparation using an extraction solvent to prepare a test solution;

[0007] Performing high performance liquid chromatography on the test sample solution to obtain a chromatogram of the corresponding test sample;

[0008] The conditions of the HPLC detection include: mobile phase A is methanol, mobile phase B is phosphoric acid aqueous solution, and gradient elution is used;

[0009] The procedure of the gradient elution includes:

[0010] 0-8min, the volume percentage of the mobile phase A is maintained at 4%;

[0011] From 8 to 20 minutes, the volume percentage of the mobile phase A increases from 4% to 15%;

[0012] From 20min to 55min, the volume percentage of the mobile phase A increases from 15% to 80%;

[0013] 55min-65min, the volume percentage of the mobile phase A is maintained at 80%;

[0014] The chromatogram of the test sample is introduced into the traditional Chinese medicine chromatographic fingerprint similarity evaluation system for processing, and the main chromatographic peaks existing in the chromatograms of different batches of test samples are selected as characteristic peaks to construct the characteristic spectrum of the Qi-invigorating and blood-retaining preparation.

[0015] In one embodiment, the Qi-invigorating and blood-replenishing preparation includes one or more of Qi-invigorating and blood-replenishing capsules, Qi-invigorating and blood-replenishing tablets, Qi-invigorating and blood-replenishing granules, and Qi-invigorating and blood-replenishing granules (without added sucrose).

[0016] In one embodiment, the volume percentage of phosphoric acid in the phosphoric acid aqueous solution is 0.02%-0.1%.

[0017] In one embodiment, the HPLC detection further satisfies at least one of the following conditions:

[0018] (1) The injection volume is 5 μL-50 μL;

[0019] (2) The detection wavelength is 190nm-400nm;

[0020] (3) Flow rate: 0.8 mL / min-1.2 mL / min;

[0021] (4) The column temperature is 25℃-35℃.

[0022] In one embodiment, the step of extracting the Qi-Yinqi-Weixue preparation using an extraction solvent satisfies at least one of the following conditions:

[0023] (1) The extraction method is one or more of ultrasonic extraction, reflux extraction, immersion extraction, decoction extraction or oscillation extraction;

[0024] (2) The extraction time is 20 min to 60 min;

[0025] (3) The extraction solvent includes methanol-water solution or methanol; optionally, the volume percentage of methanol in the methanol-water solution is 20%-95%.

[0026] In one embodiment, the weight-to-volume ratio of the Qi-invigorating and blood-maintaining preparation to the extraction solvent is (2-20) g: (15-100) mL.

[0027] In one embodiment, the method for constructing the characteristic spectrum of the Qi-invigorating and blood-replenishing preparation further comprises the following steps:

[0028] Dissolving the reference substance using a dissolving reagent to prepare a reference substance solution; the reference substance solution includes a mixed reference substance reference substance solution and a mixed reference medicinal material reference substance solution;

[0029] Performing high performance liquid chromatography on the reference substance solution to obtain a chromatogram of the corresponding reference substance;

[0030] According to the chromatogram of the reference object, common peak identification is performed on the chromatographic peaks in the characteristic spectrum of the Yiqiweixue preparation;

[0031] Wherein, the reference substances include one or more of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, calycosin, astragalus and jujube.

[0032] In one embodiment, the dissolving agent is a methanol aqueous solution or water; optionally, in the methanol aqueous solution, the volume percentage of methanol is 5%-50%.

[0033] In one embodiment, the characteristic peaks of the characteristic spectrum of the Qi-invigorating and blood-replenishing preparation include 7 characteristic peaks, of which 5 identified characteristic peaks include: characteristic peak No. 3 is guanosine, characteristic peak No. 4 is 5-hydroxymethylfurfural, characteristic peak No. 5 is calycosin glucoside, characteristic peak No. 6 is formononetin, and characteristic peak No. 7 is calycosin.

[0034] Another aspect of the present invention provides a method for constructing the characteristic spectrum of the Yiqi Weixue preparation as described above, and an application of the characteristic spectrum of the Yiqi Weixue preparation constructed in the quality control of the Yiqi Weixue preparation.

[0035] Compared with the prior art, this application has the following beneficial effects:

[0036] The present application constructs a characteristic spectrum of the Qi-Yinweixue preparation containing multiple characteristic peaks by adopting specific high-performance liquid chromatography detection and analysis conditions for the Qi-Yinweixue preparation. The method for constructing the characteristic spectrum of the Qi-Yinweixue preparation has the advantages of good stability, high precision, good repeatability, etc. after methodological verification. It can comprehensively reflect the effective ingredients contained in the Qi-Yinweixue preparation, and then objectively, comprehensively and accurately evaluate the quality of the Qi-Yinweixue preparation, which is of great significance for controlling the quality of the Qi-Yinweixue preparation and ensuring the clinical efficacy.

[0037] Furthermore, this method has the advantages of high separation efficiency, good reproducibility and high sensitivity. It can detect the complex multi-source material system of Qi-invigorating and blood-replenishing preparations, comprehensively obtain the characteristic information of the material basis of Qi-invigorating and blood-replenishing preparations, and evaluate the uniformity and stability of the quality of Qi-invigorating and blood-replenishing preparations, which is of great significance to improving the overall quality control level of Qi-invigorating and blood-replenishing preparations. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] In order to more clearly illustrate the specific implementation of the present application or the technical solutions in the prior art, the following is a brief introduction to the drawings required for the specific implementation or the prior art description. Obviously, the drawings described below are some implementations of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work. The drawings are only for further understanding of the illustrative embodiments and descriptions of the present invention, and constitute a part of the present invention, but do not constitute an improper limitation of the present invention.

[0039] Figure 1 It is a spectrum of reference solution, where S1 is mixed reference solution 1, S2 is mixed reference solution 2, S3 is jujube reference medicinal material solution, S4 is astragalus reference medicinal material solution, and S5 is mixed reference medicinal material reference solution.

[0040] Figure 2 It is a peak attribution identification spectrum, where S1 is the mixed reference substance solution 1, S2 is the mixed reference substance solution 2, S3 is the jujube reference medicinal material solution, S4 is the astragalus reference medicinal material solution, S5 is the Yiqi Weixue tablet test solution, S6 is the Yiqi Weixue granule (no sucrose added) test solution, S7 is the Yiqi Weixue granule test solution, and S8 is the Yiqi Weixue capsule test solution.

[0041] Figure 3 The chromatograms of 11 batches of Yiqiweixue tablets in one embodiment are shown.

[0042] Figure 4 It is a comparative characteristic spectrum of Yiqiweixue tablets in one embodiment.

[0043] Figure 5 The chromatograms of 15 batches of Yiqiweixue Capsules in one embodiment are shown.

[0044] Figure 6 This is a comparative characteristic spectrum of Yiqiweixue Capsule in one embodiment.

[0045] Figure 7 This is a chromatogram of 13 batches of Yiqiweixue granules (without sucrose added) in one embodiment.

[0046] Figure 8 This is a comparative characteristic spectrum of the Yiqi Weixue granules (without sucrose added) in one embodiment.

[0047] Fig. 9 The chromatograms of 15 batches of Yiqiweixue granules in one embodiment are shown.

[0048] Fig.10 This is a comparative characteristic spectrum of the Yiqi Weixue granules in one embodiment. DETAILED DESCRIPTION

[0049] The following is a further detailed description of the detection method of the characteristic spectrum of the Yiqi Weixue preparation of the present application and its characteristic spectrum and application in conjunction with specific examples. The present application can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.

[0050] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used herein in the specification of this application are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0051] Unless otherwise specified or incompatible herewith, the terms and phrases used herein shall have the following meanings:

[0052] As used herein, "one or more" refers to any one, any two, or any two or more of the listed items.

[0053] Herein, the optional scope of "and / or", "or / and", and "and / or" includes any one of two or more relevant listed items, and also includes any and all combinations of the relevant listed items, wherein said any and all combinations include any two relevant listed items, any more relevant listed items, or a combination of all relevant listed items.

[0054] Herein, “further”, “furthermore”, “particularly”, etc. are used for descriptive purposes to indicate differences in content, but should not be construed as limiting the scope of protection of the present invention.

[0055] In the present invention, when it comes to numerical ranges, unless otherwise specified, the above numerical ranges are deemed to be continuous and include the minimum and maximum values ​​of the range, as well as each value between such minimum and maximum values. Further, when a range refers to an integer, each integer between the minimum and maximum values ​​of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be merged. In other words, unless otherwise specified, all ranges disclosed herein should be understood to include any and all subranges included therein.

[0056] The percentage content involved in the present invention, unless otherwise specified, refers to mass percentage for solid-liquid mixing and solid-solid mixing, and refers to volume percentage for liquid-liquid mixing.

[0057] The percentage concentrations involved in the present invention, unless otherwise specified, refer to the final concentration. The final concentration refers to the proportion of the added component in the system after the addition of the component.

[0058] The temperature parameters in the present invention, if not specifically limited, allow both constant temperature treatment and treatment within a certain temperature range. The constant temperature treatment allows the temperature to fluctuate within the accuracy range controlled by the instrument. Fluctuations within the range of ±0.8°C, ±0.5°C, ±0.4°C, ±0.3°C, ±0.2°C, ±0.1°C are allowed. Normal temperature or room temperature in the present invention refers to no temperature control operation, generally refers to 4°C to 35°C, preferably refers to 20±5°C.

[0059] In recent years, with the rapid development of chromatography and mass spectrometry, the characteristic spectrum technology of traditional Chinese medicine has been widely used and improved. Spectroscopy (including ultraviolet, visible and infrared spectra), spectroscopy (including mass spectrometry and nuclear magnetic resonance spectroscopy), chromatography (including thin layer chromatography, high performance liquid chromatography, gas chromatography, etc.) and various instrument combination technologies can be used as research methods for the characteristic spectrum of traditional Chinese medicine. These technologies can realize the comprehensive analysis of traditional Chinese medicines, traditional Chinese medicine pieces and traditional Chinese patent medicines, and provide a reliable basis for quality control.

[0060] Among the existing detection methods for Qi-invigorating and blood-replenishing preparations, thin-layer chromatography has low separation efficiency and sensitivity, and it is difficult to detect trace components; while the content determination method of high-performance liquid chromatography has a single indicator, which only determines astragaloside I, and cannot cover the entire substance group of Qi-invigorating and blood-replenishing preparations.

[0061] Based on this, it is necessary to provide a method for constructing a characteristic spectrum of Qi-invigorating and blood-replenishing preparations. During the research process, the technical personnel of the present application found through chromatographic conditions and methodological investigations that by adopting specific HPLC conditions to detect the characteristic spectrum of Qi-invigorating and blood-replenishing preparations, a characteristic spectrum of Qi-invigorating and blood-replenishing preparations containing multiple characteristic peaks can be constructed. This method is simple, reliable, objective, and has good precision, repeatability and stability.

[0062] One aspect of the present invention provides a method for constructing a characteristic spectrum of a Qi-invigorating and blood-retaining preparation, comprising the following steps:

[0063] Extract the Yiqiweixue preparation using an extraction solvent to prepare a test solution;

[0064] Performing high performance liquid chromatography on the test sample solution to obtain a chromatogram of the corresponding test sample;

[0065] The conditions of the HPLC detection include: mobile phase A is methanol, mobile phase B is phosphoric acid aqueous solution, and gradient elution is used;

[0066] The procedure of the gradient elution includes:

[0067] 0-8min, the volume percentage of the mobile phase A is maintained at 4%;

[0068] From 8 to 20 minutes, the volume percentage of the mobile phase A increases from 4% to 15%;

[0069] From 20min to 55min, the volume percentage of the mobile phase A increases from 15% to 80%;

[0070] 55min-65min, the volume percentage of the mobile phase A is maintained at 80%;

[0071] The chromatogram of the test sample is introduced into the traditional Chinese medicine chromatographic fingerprint similarity evaluation system for processing, and the main chromatographic peaks existing in the chromatograms of different batches of test samples are selected as characteristic peaks to construct the characteristic spectrum of the Qi-invigorating and blood-retaining preparation.

[0072] Specifically, the formulation of reference maps and judgment standards for Qi-invigorating and blood-maintaining preparations usually involves testing no less than 10 batches, and generally 10 to 30 batches.

[0073] In some of the examples, the Qi-invigorating and blood-replenishing preparations include one or more of Qi-invigorating and blood-replenishing capsules, Qi-invigorating and blood-replenishing tablets, Qi-invigorating and blood-replenishing granules, and Qi-invigorating and blood-replenishing granules (without sucrose addition).

[0074] In some examples, the volume percentage of phosphoric acid in the phosphoric acid aqueous solution is 0.02%-0.1%. It is understood that the volume percentage of phosphoric acid in the phosphoric acid aqueous solution includes but is not limited to 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09% and 0.1%.

[0075] In some examples, the conditions for the HPLC detection include: the injection volume is 5 μL-50 μL. It can be understood that the injection volume for the HPLC detection includes but is not limited to 5 μL, 10 μL, 20 μL, 30 μL, 40 μL and 50 μL.

[0076] In some examples, the conditions for the HPLC detection include: a detection wavelength of 190nm-400nm. It is understandable that the detection wavelength of the HPLC detection includes but is not limited to 250nm, 255nm, 260nm, 265nm, 270nm and 275nm.

[0077] In some of the examples, the conditions for the HPLC detection include: a flow rate of 0.8 mL / min-1.2 mL / min. It is understandable that the flow rate for the HPLC detection includes but is not limited to 0.8 mL / min, 0.85 mL / min, 0.9 mL / min, 0.94 mL / min, 0.98 mL / min, 1.02 mL / min, 1.06 mL / min, 1.1 mL / min and 1.2 mL / min.

[0078] In some examples, the conditions for the HPLC detection include: a column temperature of 25° C.-35° C. It is understandable that the column temperature for the HPLC detection includes but is not limited to 25° C., 26° C., 27° C., 28° C., 29° C., 30° C., 31° C., 32° C., 33° C., 34° C. and 35° C.

[0079] In some of the examples, the conditions for the HPLC detection include: the chromatographic column uses octadecylsilane bonded silica gel as a filler.

[0080] In some of the examples, the conditions for the step of extracting the Qi-invigorating and blood-replenishing preparation using an extraction solvent include: the extraction method is one or more of ultrasonic extraction, reflux extraction, immersion extraction, decoction extraction or oscillation extraction.

[0081] In some of the examples, the conditions of the step of extracting the Yiqiweixue preparation with an extraction solvent include: the extraction time is 20min-60min. It can be understood that the extraction time includes but is not limited to 20min, 25min, 30min, 35min, 40min, 45min, 50min, 55min and 60min.

[0082] In some examples, the conditions of the step of extracting the Qi-Yiweixue preparation using an extraction solvent include: the extraction solvent includes methanol-water solution or methanol; optionally, the volume percentage of methanol in the methanol-water solution is 20%-95%. Further, the volume percentage of methanol in the methanol-water solution is 70%-95%.

[0083] In some of the examples, the weight-to-volume ratio of the Qi-invigorating and blood-retaining preparation to the extraction solvent is (2-20) g: (15-100) mL. It is understandable that the weight-to-volume ratio of the Qi-invigorating and blood-retaining preparation to the extraction solvent includes but is not limited to 3 g: 25 mL, 5 g: 25 mL, 3 g: 35 mL, 5 g: 35 mL, 3 g: 50 mL, 5 g: 50 mL. Furthermore, the weight-to-volume ratio of the Qi-invigorating and blood-retaining preparation to the extraction solvent is (3-15) g: (25-50) mL.

[0084] In some of the examples, the method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation further includes the following steps:

[0085] Dissolving the reference substance using a dissolving reagent to prepare a reference substance solution; the reference substance solution includes a mixed reference substance reference substance solution and a mixed reference medicinal material reference substance solution;

[0086] Performing high performance liquid chromatography on the reference substance solution to obtain a chromatogram of the corresponding reference substance;

[0087] According to the chromatogram of the reference object, common peak identification is performed on the chromatographic peaks in the characteristic spectrum of the Yiqiweixue preparation;

[0088] Wherein, the reference substances include one or more of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, calycosin, astragalus and jujube.

[0089] In some of the examples, the concentrations of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin and calycosin in the mixed control reference solution are 10 μg / mL-30 μg / mL.

[0090] In some of the examples, the preparation steps of the mixed control medicinal material reference solution include: taking 1g of Astragalus membranaceus and 1g of Jujube medicinal material, diluting it 50 times with 10% methanol aqueous solution, reflux extraction, centrifuging at a speed of 4000r / min, and taking the supernatant after centrifugation for 10 minutes; the amount of the supernatant taken is 25mL.

[0091] In some of the examples, the conditions for preparing the test solution include: ultrasonic conditions of 250W, 40kHz, and the filtrate obtained after evaporation is 10mL-30mL.

[0092] In some examples, the dissolving agent is a methanol-water solution or water; optionally, in the methanol-water solution, the volume percentage of methanol is 5%-50%.

[0093] In some of the examples, the characteristic peaks of the characteristic spectrum of the Yiqi Weixue preparation include 7 characteristic peaks, of which 5 identified characteristic peaks include: characteristic peak No. 3 is guanosine, characteristic peak No. 4 is 5-hydroxymethylfurfural, characteristic peak No. 5 is calycosin glucoside, characteristic peak No. 6 is formononetin, and characteristic peak No. 7 is calycosin.

[0094] In some of the examples, the characteristic spectrum of the Qi-invigorating and blood-replenishing preparation stipulates that the relative retention time of characteristic peak No. 1 is 0.18, and the relative retention time of characteristic peak No. 2 is 0.28. The values ​​are determined by comprehensive analysis of the results of sampling from multiple batches of different dosage forms and different instruments. It is required that in the subsequent detection process using this method, the relative retention time of characteristic peak No. 1 and characteristic peak No. 2 shall not exceed ±10%, and the RSD% of multiple sampling results shall not exceed 3%.

[0095] In one specific example, the method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation comprises the following steps:

[0096] (1) Preparation of reference solution:

[0097] Mixed reference substance solution 1: Weigh appropriate amount of guanosine and 5-hydroxymethylfurfural reference substances, add 10% methanol to dissolve, dilute to the scale, shake well, filter, and take the filtrate to obtain.

[0098] Mixed reference substance solution 2: Weigh appropriate amounts of calycosin glucoside, formononetin, and calycosin reference substance, add 50% methanol to dissolve, and dilute to the mark, shake well, filter, and take the filtrate to obtain.

[0099] Mixed control medicinal material reference solution: weigh appropriate amount of astragalus control medicinal material and jujube control medicinal material, add 10% methanol for reflux extraction, centrifuge, take appropriate amount of supernatant and evaporate to dryness, add 10% methanol to dissolve the residue, transfer to a volumetric flask, add 10% methanol to dilute to the scale line, shake well, filter, and take the filtrate to obtain.

[0100] (2) Preparation of test solution:

[0101] Yiqiweixue Tablets: Take an appropriate amount of sample, grind it into powder, take an appropriate amount of fine powder, weigh it accurately, put it in a conical flask, add an appropriate amount of methanol accurately, weigh it, treat it with ultrasound, let it cool, weigh it again, make up the lost weight with methanol, shake it well, filter it, accurately measure an appropriate amount of filtrate, evaporate it to dryness, dissolve the residue in water, transfer it to a volumetric flask, dilute it to the scale line with water, shake it well, filter it, take the filtrate, and you are done.

[0102] Yiqiweixue Capsules: Take an appropriate amount of sample, grind it into powder, take an appropriate amount of fine powder, weigh it accurately, put it in a conical flask, add an appropriate amount of methanol accurately, weigh it, treat it with ultrasound, let it cool, weigh it again, make up the lost weight with methanol, shake it well, filter it, accurately measure an appropriate amount of filtrate, evaporate it to dryness, dissolve the residue in water, transfer it to a volumetric flask, dilute it to the scale line with water, shake it well, filter it, take the filtrate, and you are done.

[0103] Yiqi Weixue Granules: Take an appropriate amount of sample, grind it into powder, take an appropriate amount of fine powder, weigh it accurately, put it in a conical flask, add an appropriate amount of 90% methanol accurately, weigh it, treat it with ultrasound, let it cool, weigh it again, make up the lost weight with 90% methanol, shake it well, filter it, accurately measure an appropriate amount of filtrate, evaporate it to dryness, dissolve the residue in water, transfer it to a volumetric flask, dilute it to the scale line with water, shake it well, filter it, take the filtrate, and you are done.

[0104] Yiqi Weixue Granules (without added sucrose): Take an appropriate amount of sample, grind it into powder, take an appropriate amount of fine powder, weigh it accurately, put it in a conical flask, add an appropriate amount of 90% methanol accurately, weigh it, treat it with ultrasound, let it cool, weigh it again, make up the lost weight with 90% methanol, shake it well, filter it, accurately measure an appropriate amount of filtrate, evaporate it to dryness, dissolve the residue in water, transfer it to a volumetric flask, dilute it to the scale line with water, shake it well, filter it, take the filtrate, and you are done.

[0105] (3) Chromatographic conditions

[0106] The results were detected by high performance liquid chromatography, the chromatographic column was filled with octadecylsilane bonded silica gel, the mobile phase A was methanol, the mobile phase B was phosphoric acid aqueous solution, and gradient elution was used;

[0107] The procedure of the gradient elution includes:

[0108] 0-8min, the volume percentage of the mobile phase A is maintained at 4%;

[0109] From 8 to 20 minutes, the volume percentage of the mobile phase A increases from 4% to 15%;

[0110] From 20min to 55min, the volume percentage of the mobile phase A increases from 15% to 80%;

[0111] From 55 min to 65 min, the volume percentage of the mobile phase A is maintained at 80%.

[0112] (4) Characteristic spectrum determination

[0113] The reference solution of step (1) and the test solution of step (2) are respectively injected into a high performance liquid chromatograph, and the chromatographic conditions of step (3) are used for detection to obtain the corresponding chromatograms of the reference and the test sample, and the relative retention time of each characteristic peak is calculated.

[0114] (5) Establishment of reference characteristic map

[0115] The chromatogram of the test sample is introduced into the traditional Chinese medicine chromatographic fingerprint similarity evaluation system for processing, and the main chromatographic peaks existing in the chromatograms of different batches of test samples are selected as characteristic peaks to construct a control characteristic spectrum of the Qi-invigorating and blood-replenishing preparation.

[0116] Another aspect of the present invention provides a method for constructing the characteristic spectrum of the Yiqi Weixue preparation as described above, and an application of the characteristic spectrum of the Yiqi Weixue preparation constructed in the quality control of the Yiqi Weixue preparation.

[0117] The present invention is further described in detail below in conjunction with specific examples. For experimental parameters not specified in the following specific examples, reference is made to the instructions given in this application document, and reference may also be made to the experimental manuals in the art or other experimental methods known in the art, or to the experimental conditions recommended by the manufacturer. It is understood that the instruments and raw materials used in the following examples are relatively specific, and may not be limited thereto in other specific examples.

[0118] Some of the instruments and materials used in the examples are as follows:

[0119] Instruments: HPLC LC-2050 (Shimadzu Malaysia Factory); HPLC Agilent 1260II (Agilent China Technology Co., Ltd.); UV detector (DAD); SQP electronic analytical balance (Sartorius Scientific Instruments (Beijing) Co., Ltd.); JA5003 electronic analytical balance (Shanghai Sunny Optical Hengping Scientific Instruments Co., Ltd.); KQ5200DE ultrasonic cleaner (Kunshan Ultrasonic Instruments Co., Ltd.).

[0120] Reference substances: guanosine (batch number 111977-202202), 5-hydroxymethylfurfural (batch number 111626-202316), calycosin glucoside (batch number: 111920-201907), calycosin (batch number: 112117-202301), astragalus reference medicinal material (batch number: 120974-201813), and jujube reference medicinal material (121093-201809) were all purchased from China Food and Drug Inspection Institutes; formononetin (batch number 15943) and calycosin (batch number: 15747) were purchased from Shanghai Stand Standard Technical Service Co., Ltd.

[0121] Reagents: methanol (chromatographic grade); acetonitrile (chromatographic grade); methanol (analytical grade); phosphoric acid (analytical grade); ultrapure water.

[0122] Test samples: Yiqiweixue tablets (batch numbers: 20190718, 20190816, 20190916, 20210309, 20220401S, 20220601, 20220701, 20220702, 20221201S, 20221202S, 20221203S; specification: 0.57 g / tablet; source: Guangdong Hongshanhu Pharmaceutical Co., Ltd.); Yiqiweixue capsules (batch number: 2022101 2. 20221104, 20221113, 20231005, 20230203, 20230521, 20231010, 20231001, 20231104, 20231106, 20240304, 20240306, 20240514, 20240515; Specification: 0.45g / tablet; Source: Guangdong Red Coral Pharmaceutical Co., Ltd.); Yiqiweixue Granules (no sucrose added) (Batch No.: 20220801, 20220802, 20220803, 20230401, 20230402, 20230403, 20230404, 20231201S, 20231202S, 20240101S, 20240102S, 20240301S, 20240302S; Specification: 5g / bag; Source: Guangdong Hongshanhu Pharmaceutical Co., Ltd.); Yiqiweixue Granules (Batch No. : 20220801, 20220905, 20221001, 20221106, 20221202, 20230808, 20231010, 20231109, 10231209, 20231214, 20240110, 20240207, 20240412, 20240502, 20240503; Specification: 10g / bag; Source: Guangdong Red Coral Pharmaceutical Co., Ltd.).

[0123] Investigation Example 1

[0124] In the research scheme of the characteristic spectrum of the Yiqiweixue preparation of the present application, the inventors of the present application have carried out corresponding optimization of the reference solution preparation steps, the test sample preparation steps, the chromatographic condition steps, the characteristic spectrum determination steps, and the control characteristic spectrum establishment steps after a large number of experimental explorations, and obtained a stable, reliable, and easy-to-operate detection method. The preferred partial screening schemes in the research technology of the present application are provided as follows:

[0125] 1. Preparation of reference solution

[0126] In the reference solution preparation step of the present application, the final solvents of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin and calycosin reference substances were investigated, and 10%, 20%, 50%, 80% and 100% methanol aqueous solutions were investigated respectively. The results showed that guanosine and 5-hydroxymethylfurfural reference substances were stable in 10% methanol and had no solvent effect; calycosin glucoside, formononetin and calycosin was stable in 50% methanol solution and had no solvent effect.

[0127] In the preparation steps of the mixed control medicinal material reference solution, water, 10% methanol, and 40% methanol extraction solvents were investigated, heating reflux and ultrasonic extraction methods were investigated, and extraction time was investigated. The optimal preparation method was 10% methanol reflux extraction for 2 hours, 25 mL of the supernatant was taken after centrifugation, evaporated to dryness, 10% methanol was used to dissolve the residue, transferred to a 2 mL volumetric flask, fixed to volume, filtered, and the filtrate was taken.

[0128] 2. Preparation of test solution

[0129] In the preparation step of the test solution, the present application investigates the mass volume ratio of the sample to the extraction solvent, and its range includes but is not limited to (3g~20g): (20mL~60mL); the extraction solvent investigates its range includes but is not limited to methanol, ethanol and methanol aqueous solution and ethanol aqueous solution in different volume ratios; the extraction method investigates (reflux, ultrasound); and the extraction time investigates (20min~60min).

[0130] The results showed that the most preferred solution of Yiqi Weixue tablets was 5 g: 25 mL (methanol), which was treated with ultrasound (250 W, 40 kHz) for 60 min; the most preferred solution of Yiqi Weixue capsules was 3.5 g: 25 mL (methanol), which was treated with ultrasound (250 W, 40 kHz) for 60 min; the most preferred solution of Yiqi Weixue granules was 15 g: 50 mL (90% methanol), which was treated with ultrasound (250 W, 40 kHz) for 40 min; and the most preferred solution of Yiqi Weixue granules (without sucrose added) was 5 g: 50 mL (90% methanol), which was treated with ultrasound (250 W, 40 kHz) for 40 min.

[0131] 3. Screening of HPLC Conditions

[0132] 3.1 Elution gradient screening and detection wavelength selection

[0133] By consulting the literature to determine the properties of the ingredients contained in the prescription medicine, methanol-0.05% phosphoric acid was preliminarily selected as the mobile phase. The present application uses a diode array detector for detection, and when conducting the mobile phase elution gradient investigation, the full wavelength (190nm-400nm scanning) is turned on; after adjustment and screening, the tentative chromatographic conditions are obtained, and the detection wavelength is 272nm. At this wavelength, the chromatographic peak response value is better and the baseline is flat; the gradient elution program is 0-8min, and the volume percentage of methanol is maintained at 4%; 8min-20min, the volume percentage of methanol is 4%→15%; 20min-55min, the volume percentage of methanol is 15%→80%; 55min-65min, the volume percentage of methanol is maintained at 80%.

[0134] 3.2 Investigation of mobile phase components

[0135] The present invention compares the elution effects of multiple different elution systems such as acetonitrile-0.1% formic acid, acetonitrile-0.02% formic acid, acetonitrile-water, methanol-water, methanol-0.1% phosphoric acid, methanol-0.05% phosphoric acid and methanol-0.02% phosphoric acid. The results show that when methanol and 0.05% phosphoric acid solution are used as mobile phases, the components in the Qi-Yi-Weixue preparation can achieve a good separation effect, so methanol and 0.05% phosphoric acid solution are finally selected as the mobile phase.

[0136] 3.3 Flow rate, column temperature, chromatographic column, injection volume investigation and screening

[0137] This application compares the flow rates of 0.9mL / min, 1.0mL / min, and 1.1mL / min, and the results show that 1.0mL / min is the most preferred. The column temperature was investigated at 28°C to 32°C, and 30°C is the most preferred. The chromatographic column investigated chromatographic columns with octadecylsilane bonded silica gel as fillers from different manufacturers and different models, and ZORBAX SB-C18 was ultimately the most preferred. The injection volume was investigated, including but not limited to 20μL to 60μL, and 30μL was the most preferred.

[0138] 3.4 Characteristic peak selection and identification results in this application

[0139] In the process of establishing the characteristic spectrum of the Yiqiweixue preparation, 7 characteristic peaks were selected by consulting relevant literature and regulatory requirements, and peak 5 was the reference peak S, see Figure 1 At the same time, the 7 characteristic peaks were identified, of which the reference substance identified 5 characteristic peaks, corresponding to 5 different components, characteristic peak No. 3 was guanosine, characteristic peak No. 4 was 5-hydroxymethylfurfural, characteristic peak No. 5 (reference peak S) was calycosin glucoside, characteristic peak No. 6 was formononetin, characteristic peak No. 7 was calycosin, characteristic peak No. 1 that was not identified by the reference substance was a common peak of jujube and astragalus, characteristic peak No. 2 was a peak exclusive to jujube, and the identification chromatograms are detailed in Figure 2The identification results are shown in Table 1:

[0140] Table 1 Characteristic peak identification results

[0141]

[0142] Example 1

[0143] This embodiment provides the detection of the characteristic spectrum of Yiqiweixue tablets, which is as follows:

[0144] Step 1: Preparation of reference solution:

[0145] Mixed control medicinal material reference solution: Take 1g of astragalus control medicinal material and 1g of jujube control medicinal material respectively, place in a stoppered conical flask, accurately add 50mL of 10% methanol, weigh the weight, heat and reflux for 2h, cool, weigh again, make up the lost weight with 10% methanol, shake well, centrifuge (4000r / min) for 10min, accurately measure 25mL of supernatant, evaporate to dryness, dissolve the residue in 10% methanol, transfer to a 2mL volumetric flask, dilute to the scale with 10% methanol, shake well, filter, and take the filtrate as the mixed control medicinal material reference solution.

[0146] Mixed reference substance solution 1: Accurately weigh appropriate amounts of guanosine and 5-hydroxymethylfurfural standards, add 10% methanol to make a solution containing about 20 μg of guanosine and 5-hydroxymethylfurfural per 1 mL, filter, and take the filtrate as reference substance solution 1.

[0147] Mixed reference substance solution 2: Accurately weigh appropriate amounts of standard substances of isoflavone glucoside, formononetin and isoflavone, respectively, add 50% methanol to prepare a solution containing about 20 μg of isoflavone glucoside, formononetin and isoflavone per 1 mL, filter and take the filtrate as reference substance solution 2.

[0148] Step 2. Preparation of test solution: Take an appropriate amount of sample, grind it into powder, take about 5g of fine powder, accurately weigh it, put it in a conical flask, accurately add 25mL of methanol, weigh it, ultrasonically treat it (power 200w, frequency 40KHz) for 60 minutes, let it cool, weigh it again, make up the lost weight with methanol, shake it well, filter it, accurately measure 15mL of the filtrate, evaporate it to dryness, dissolve the residue in water, transfer it to a 2mL volumetric flask, dilute it to the scale with water, shake it well, filter it, and take the filtrate.

[0149] Step 3, liquid chromatography conditions: The chromatographic column uses ZORBAX SB-C18 (250×4.6mm, 5μm) model, methanol is used as mobile phase A, 0.05% phosphoric acid solution is used as mobile phase B, gradient elution is performed, the detection wavelength is 272nm, the column temperature is 30°C, and the flow rate is 1mL / min. The gradient elution program is: from 0 to 8min, mobile phase A is maintained at 4%, and mobile phase B is maintained at 96%; from 8min to 20min, mobile phase A increases from 4% to 15%, and mobile phase B decreases from 96% to 85%; from 20min to 55min, mobile phase A increases from 15% to 80%, and mobile phase B decreases from 85% to 20%; from 55min to 65min, mobile phase A is maintained at 80%, and mobile phase B is maintained at 20%.

[0150] Step 4, determination: accurately aspirate the reference solution and take 30 μL of each of the 11 batches of test solution prepared by the preparation method of the test solution in step 2 of Yiqiweixue Tablets, inject them into the high performance liquid chromatograph for detection, and record the chromatogram, such as Figure 3 The chromatograms of the test solutions of 11 batches of Yiqiweixue tablets were respectively introduced into the Chinese medicine chromatographic fingerprint similarity evaluation system; the 7 main chromatographic peaks existing in the chromatograms of each batch of Yiqiweixue tablets were selected as characteristic peaks; the control characteristic spectrum of Yiqiweixue tablets was generated by the average value calculation method, see Figure 4 . In the characteristic spectra of 11 batches of Yiqiweixue tablets, characteristic peak No. 3 is guanosine, with an average retention time of 11.903min, characteristic peak No. 4 is 5-hydroxymethylfurfural, with an average retention time of 15.356min, characteristic peak No. 5 is calycosin glucoside, with an average retention time of 36.932min, characteristic peak No. 6 is formononetin, with an average retention time of 42.637min, and characteristic peak No. 7 is calycosin, with an average retention time of 45.807min; the peak corresponding to the reference peak of calycosin glucoside is the S peak (characteristic peak No. 5), and the relative retention time of the unidentified characteristic peaks No. 1 and No. 2 is calculated. The average relative retention times of the 11 batches are: 0.181 (characteristic peak No. 1), 0.282 (characteristic peak No. 2).

[0151] The methodological study of the characteristic spectrum detection method of Yiqiweixue Tablets is as follows:

[0152] (1) Precision study

[0153] Take Yiqiweixue Tablets (batch number: 20221201S) and prepare the test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and inject 6 times in parallel. The test sample characteristic spectrum should show 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatogram peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 2 below. The results show that the parallel injection precision of this method is good.

[0154] Table 2 Precision study results of Yiqiweixue tablets

[0155]

[0156] (2) Reproducibility study

[0157] Weigh 6 samples of Yiqiweixue Tablets (batch number: 20221201S) in parallel and prepare 6 test solution according to the method of step 2. Analyze according to the detection method of step 3. The test sample characteristic spectrum should show 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material. Among them, characteristic peaks 3, 4, 5, 6 and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin and calycosin reference substance chromatogram peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5). Calculate the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 3 below. The results show that the method has good repeatability.

[0158] Table 3 Results of the reproducibility study of Yiqiweixue tablets

[0159]

[0160] (3) Stability study

[0161] Take Yiqiweixue Tablets (batch number: 20221201S) and prepare the test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and use 0, 5, 10, 15, 20, and 25 hours for sampling and analysis. The test sample characteristic spectrum presents 7 characteristic peaks and corresponds to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material reference. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatographic peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak No. 1), 0.28 (characteristic peak No. 2). The retention time / relative retention time of each characteristic peak is summarized in Table 4 below. The results show that the chromatographic peak of the Yiqiweixue tablets test solution has almost no change within 25 hours, and the method has good stability.

[0162] Table 4 Results of stability study on Yiqiweixue tablets

[0163]

[0164] Example 2

[0165] This embodiment provides the detection of the characteristic spectrum of Yiqiweixue Capsule, which is as follows:

[0166] Step 1: Preparation of reference solution: same as in Example 1.

[0167] Step 2. Preparation of test solution: Take an appropriate amount of sample, grind it into powder, take about 3.5g of fine powder, accurately weigh it, put it in a conical flask, accurately add 25mL of methanol, weigh it, ultrasonically treat it (power 200w, frequency 40KHz) for 60 minutes, let it cool, weigh it again, make up the lost weight with methanol, shake it well, filter it, accurately measure 10mL of the filtrate, evaporate it to dryness, dissolve the residue in water, transfer it to a 2mL volumetric flask, dilute it to the scale with water, shake it well, filter it, and take the filtrate.

[0168] Step 3, liquid chromatography conditions: same as in Example 1.

[0169] Step 4, determination: accurately aspirate the reference solution and take 30 μL of each of the 15 batches of Yiqiweixue Capsules prepared according to the preparation method of the test solution in step 2, inject them into the high performance liquid chromatograph for detection, and record the chromatogram, see Figure 5The chromatograms of the test solutions of 15 batches of Yiqiweixue Capsules were respectively introduced into the Chinese medicine chromatographic fingerprint similarity evaluation system, and the 7 main chromatographic peaks existing in the chromatograms of each batch of Yiqiweixue Capsules were selected as characteristic peaks; the control characteristic spectrum of Yiqiweixue Capsules was generated by the average value calculation method, see Figure 6 . In the characteristic spectra of 15 batches of Yiqiweixue Capsules, characteristic peak No. 3 is guanosine, with an average retention time of 11.917min, characteristic peak No. 4 is 5-hydroxymethylfurfural, with an average retention time of 15.384min, characteristic peak No. 5 is calycosin glucoside, with an average retention time of 36.936min, characteristic peak No. 6 is formononetin, with an average retention time of 42.627min, and characteristic peak No. 7 is calycosin, with an average retention time of 45.802min; the peak corresponding to the reference peak of calycosin glucoside is the S peak (characteristic peak No. 5), and the relative retention time of the unidentified characteristic peaks No. 1 and No. 2 is calculated. The average relative retention times of the 15 batches are: 0.181 (characteristic peak No. 1) and 0.282 (characteristic peak No. 2).

[0170] The methodological study of the characteristic spectrum detection method of Yiqiweixue Capsule is as follows:

[0171] (1) Precision study

[0172] Take Yiqiweixue Capsule (batch number: 20221012) and prepare the test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and inject 6 times in parallel. The test sample characteristic spectrum should show 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatogram peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 5 below. The results show that the parallel injection precision of this method is good.

[0173] Table 5 Precision study results of Yiqiweixue Capsules

[0174]

[0175] (2) Reproducibility study

[0176] Weigh 6 portions of Yiqiweixue Capsules (batch number: 20221012) in parallel, prepare 6 portions of test solution according to the method of step 2, and analyze according to the detection method of step 3. The test sample characteristic spectrum should show 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of the chromatogram peaks of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance. The peak corresponding to the calycosin glucoside reference substance peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 6 below. The results show that the method has good repeatability.

[0177] Table 6 Results of the repeatability study of Yiqiweixue Capsules

[0178]

[0179] (3) Stability study

[0180] Take Yiqiweixue Capsule (batch number: 20221012) and prepare the test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and use 0, 5, 10, 15, 20, and 25 hours for sampling and analysis. The test sample characteristic spectrum presents 7 characteristic peaks and corresponds to the retention time of the 7 characteristic peaks in the reference chromatogram of the reference medicinal material. Among them, characteristic peaks 3, 4, 5, 6, and 7 correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatographic peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak No. 1), 0.28 (characteristic peak No. 2). The retention time / relative retention time of each characteristic peak is summarized in Table 7 below. The results show that the chromatographic peak of the Yiqiweixue Capsule test solution has almost no change within 25 hours, and the method has good stability.

[0181] Table 7 Stability study results of Yiqiweixue capsules

[0182]

[0183] Example 3

[0184] This embodiment provides the detection of the characteristic spectrum of Yiqiweixue granules (no sucrose added), which is as follows:

[0185] Step 1: Preparation of reference solution: same as in Example 1.

[0186] Step 2. Preparation of test solution: Take an appropriate amount of sample, grind it, take about 5g of fine powder, accurately weigh it, put it in a conical flask, accurately add 50mL of 90% methanol, weigh the weight, ultrasonically treat (power 200w, frequency 40KHz) for 40 minutes, cool, weigh the weight again, make up the lost weight with 90% methanol, shake well, filter, accurately measure 25mL of the filtrate, evaporate to dryness, dissolve the residue in water, transfer it to a 2mL volumetric flask, dilute to the scale with water, shake well, filter, and take the filtrate.

[0187] Step 3, liquid chromatography conditions: same as in Example 1.

[0188] Step 4: Accurately pipette the reference solution and 13 batches of Yiqiweixue granules (without sucrose addition) and prepare 30 μL of each of the 13 batches of test solution prepared according to the preparation method of the test solution in step 2, inject them into the high performance liquid chromatograph for detection, and record the chromatogram. Figure 7 The chromatograms of the test solutions of 13 batches of Yiqiweixue granules were respectively introduced into the Chinese medicine chromatographic fingerprint similarity evaluation system; the 7 main chromatographic peaks existing in the chromatograms of each batch of Yiqiweixue granules (without sucrose addition) were selected as characteristic peaks; the control characteristic spectrum of Yiqiweixue capsule was generated by the average value calculation method, see Figure 8 . In the characteristic spectra of 13 batches of Yiqiweixue Granules (no sucrose added), characteristic peak No. 3 is guanosine, with an average retention time of 11.874min, characteristic peak No. 4 is 5-hydroxymethylfurfural, with an average retention time of 15.333min, characteristic peak No. 5 is calycosin glucoside, with an average retention time of 36.946min, characteristic peak No. 6 is formononetin, with an average retention time of 42.654min, and characteristic peak No. 7 is calycosin, with an average retention time of 45.712min; the peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak No. 5), and the relative retention time of the unidentified characteristic peaks No. 1 and No. 2 is calculated. The average relative retention times of the 13 batches are: 0.181 (characteristic peak No. 1) and 0.281 (characteristic peak No. 2).

[0189] The methodological study of the characteristic spectrum detection method of Yiqiweixue Granules (without sucrose addition) is as follows:

[0190] (1) Precision study

[0191] Take Yiqiweixue Granules (no sucrose added) (batch number: 20230403) and prepare a test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and inject 6 times in parallel. The test sample characteristic spectrum should show 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material reference. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatogram peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 8 below. The results show that the parallel injection precision of this method is good.

[0192] Table 8 Precision study results of Yiqiweixue granules (no sucrose added)

[0193]

[0194] (2) Reproducibility study

[0195] Weigh 6 portions of Yiqiweixue Granules (no sucrose added) (batch number: 20230403) in parallel, prepare 6 portions of test solution according to the method of step 2, and analyze according to the detection method of step 3. The test sample characteristic spectrum should show 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of the chromatogram peaks of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance. The peak corresponding to the calycosin glucoside reference substance peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 9 below. The results show that the method has good repeatability.

[0196] Table 9 Repeatability study results of Yiqiweixue granules (no sucrose added)

[0197]

[0198] (3) Stability study

[0199] Take Yiqiweixue Granules (no sucrose added) (batch number: 20230403) and prepare the test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and use 0, 5, 10, 15, 20, and 25 hours for sampling and analysis. The test sample characteristic spectrum presents 7 characteristic peaks and corresponds to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material reference. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatographic peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak No. 1), 0.28 (characteristic peak No. 2). The retention time / relative retention time of each characteristic peak is summarized in Table 10 below. The results show that the chromatographic peak of the Yiqi Weixue Granule (no sucrose added) test solution has almost no change within 25 hours, and the method has good stability.

[0200] Table 10 Stability study results of Yiqiweixue granules (no sucrose added)

[0201]

[0202] Example 4

[0203] This embodiment provides the detection of the characteristic spectrum of Yiqiweixue granules, which is as follows:

[0204] Step 1: Preparation of reference solution: same as in Example 1.

[0205] Step 2. Preparation of test solution: Take an appropriate amount of sample, grind it into powder, take about 15g of fine powder, accurately weigh it, put it in a conical flask, accurately add 50mL of 90% methanol, weigh the weight, ultrasonically treat (power 200w, frequency 40KHz) for 40 minutes, let cool, weigh the weight again, make up the lost weight with 90% methanol, shake well, filter, accurately measure 30mL of the filtrate, evaporate to dryness, dissolve the residue in water, transfer it to a 5mL volumetric flask, dilute to the scale with water, shake well, filter, and take the filtrate.

[0206] Step 3, liquid chromatography conditions: same as in Example 1.

[0207] Step 4: Accurately pipette the reference solution and 30 μL of each of the 15 batches of Yiqiweixue granules prepared according to the preparation method of the test solution in step 2, inject them into the high performance liquid chromatograph for detection, and record the chromatogram. Fig. 9The chromatograms of the test solutions of 15 batches of Yiqiweixue granules were respectively introduced into the Chinese medicine chromatographic fingerprint similarity evaluation system; the 7 main chromatographic peaks existing in the chromatograms of each batch of Yiqiweixue tablets were selected as characteristic peaks; the control characteristic spectrum of Yiqiweixue tablets was generated by the average value calculation method, see Fig.10 . In the characteristic spectra of 15 batches of Yiqiweixue Capsules, characteristic peak No. 3 is guanosine, with an average retention time of 12.048min, characteristic peak No. 4 is 5-hydroxymethylfurfural, with an average retention time of 15.532min, characteristic peak No. 5 is calycosin glucoside, with an average retention time of 36.988min, characteristic peak No. 6 is formononetin, with an average retention time of 42.765min, and characteristic peak No. 7 is calycosin, with an average retention time of 45.884min; the peak corresponding to the reference peak of calycosin glucoside is the S peak (characteristic peak No. 5), and the relative retention time of the unidentified characteristic peaks No. 1 and No. 2 is calculated. The average relative retention times of the 15 batches are: 0.183 (characteristic peak No. 1) and 0.286 (characteristic peak No. 2).

[0208] The methodological study of the characteristic spectrum detection method of Yiqiweixue granules is as follows:

[0209] (1) Precision study

[0210] Take Yiqiweixue Granule (batch number: 20231209) and prepare a test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and inject 6 times in parallel. The test sample characteristic spectrum should show 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the mixed control medicinal material reference solution. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatographic peaks. The peak corresponding to the calycosin glucoside reference substance peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 11 below. The results show that the parallel injection precision of this method is good.

[0211] Table 11 Precision study results of Yiqiweixue granules

[0212]

[0213] (2) Reproducibility study

[0214] Six portions of Yiqiweixue granules (batch number: 20231209) were accurately weighed in parallel, and six portions of test solution were prepared according to the method of step 2. According to the detection method of step 3, the test sample characteristic spectrum should present 7 characteristic peaks and correspond to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of the chromatogram peaks of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance. The peak corresponding to the calycosin glucoside reference substance peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak 1) and 0.28 (characteristic peak 2). The retention time / relative retention time of each characteristic peak is summarized in Table 12 below. The results show that the method has good repeatability.

[0215] Table 12 Results of the repeatability study of Yiqiweixue granules

[0216]

[0217] (3) Stability study

[0218] Take Yiqiweixue granules (batch number: 20231209) and prepare the test solution according to the test solution method in step 2. Analyze according to the detection method in step 3, and use 0, 5, 10, 15, 20, and 25 hours for sampling and analysis. The test sample characteristic spectrum presents 7 characteristic peaks and corresponds to the retention time of the 7 characteristic peaks in the chromatogram of the reference medicinal material reference. Among them, characteristic peaks 3, 4, 5, 6, and 7 should correspond to the retention time of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, and calycosin reference substance chromatographic peaks. The peak corresponding to the calycosin glucoside reference peak is the S peak (characteristic peak 5), and the relative retention time of the unidentified characteristic peaks 1 and 2 and the S peak is calculated. The relative retention time is within ±10% and the RSD value is within ±3%. The specified values ​​are: 0.18 (characteristic peak No. 1), 0.28 (characteristic peak No. 2). The retention time / relative retention time of each characteristic peak is summarized in Table 13 below. The results show that the chromatographic peak of the Yiqiweixue granule test solution has almost no change within 25 hours, and the method has good stability.

[0219] Table 13 Results of stability study on Yiqiweixue granules

[0220]

[0221] The control characteristic spectra obtained in Examples 1, 2, 3 and 4 are similar, and the 7 characteristic peaks are common to the 4 dosage forms, and the relative retention time of each unmarked characteristic peak is within ±10% of the specified value, and the RSD% range is between 0.00% and 0.45%, which is much less than the specified ±3%. The above experimental results show that the characteristic spectrum detection method of the Yiqi Weixue preparation (Yiqi Weixue Tablets, Yiqi Weixue Capsules, Yiqi Weixue Granules, Yiqi Weixue Granules (without sucrose addition)) provided by the present application has good stability, high precision, good repeatability, and can comprehensively and objectively evaluate the quality of the Yiqi Weixue preparation, which is of great significance for ensuring clinical efficacy.

[0222] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0223] The above-mentioned embodiments only express several implementation methods of the present invention, and the description is relatively specific and detailed, but it cannot be understood as limiting the scope of the invention patent. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be based on the attached claims, and the description can be used to interpret the content of the claims.

Claims

1. A method for constructing a characteristic spectrum of a Qi-invigorating and blood-replenishing preparation, characterized in that: The following steps are involved: Extract the Yiqiweixue preparation using an extraction solvent to prepare a test solution; Performing high performance liquid chromatography on the test sample solution to obtain a chromatogram of the corresponding test sample; The conditions of the HPLC detection include: mobile phase A is methanol, mobile phase B is phosphoric acid aqueous solution, and gradient elution is used; The procedure of the gradient elution includes: 0-8min, the volume percentage of the mobile phase A is maintained at 4%; From 8 to 20 minutes, the volume percentage of the mobile phase A increases from 4% to 15%; From 20min to 55min, the volume percentage of the mobile phase A increases from 15% to 80%; 55min-65min, the volume percentage of the mobile phase A is maintained at 80%; The chromatogram of the test sample is introduced into the traditional Chinese medicine chromatographic fingerprint similarity evaluation system for processing, and the main chromatographic peaks existing in the chromatograms of different batches of test samples are selected as characteristic peaks to construct the characteristic spectrum of the Qi-invigorating and blood-retaining preparation.

2. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation according to claim 1, characterized in that: The Qi-invigorating and blood-replenishing preparations include one or more of Qi-invigorating and blood-replenishing capsules, Qi-invigorating and blood-replenishing tablets, Qi-invigorating and blood-replenishing granules, and Qi-invigorating and blood-replenishing granules (without sucrose addition).

3. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation according to claim 1, characterized in that: In the phosphoric acid aqueous solution, the volume percentage of phosphoric acid is 0.02%-0.1%.

4. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation according to claim 1, characterized in that: The high performance liquid chromatography detection also satisfies at least one of the following conditions: (1) The injection volume is 5 μL-50 μL; (2) The detection wavelength is 190nm-400nm; (3) Flow rate: 0.8 mL / min-1.2 mL / min; (4) The column temperature is 25℃-35℃.

5. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation according to claim 1, characterized in that: The step of extracting the Qi-Yi-Weixue preparation using an extraction solvent satisfies at least one of the following conditions: (1) The extraction method is one or more of ultrasonic extraction, reflux extraction, immersion extraction, decoction extraction or oscillation extraction; (2) The extraction time is 20 min to 60 min; (3) The extraction solvent includes methanol-water solution or methanol; optionally, the volume percentage of methanol in the methanol-water solution is 20%-95%.

6. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-replenishing preparation according to claim 1, characterized in that: The weight-to-volume ratio of the Qi-invigorating and blood-replenishing preparation to the extraction solvent is (2-20) g: (15-100) mL.

7. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-replenishing preparation according to any one of claims 1 to 6, characterized in that: The method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation further comprises the following steps: Dissolving the reference substance using a dissolving reagent to prepare a reference substance solution; the reference substance solution includes a mixed reference substance reference substance solution and a mixed reference medicinal material reference substance solution; Performing high performance liquid chromatography on the reference substance solution to obtain a chromatogram of the corresponding reference substance; According to the chromatogram of the reference object, common peak identification is performed on the chromatographic peaks in the characteristic spectrum of the Yiqiweixue preparation; Wherein, the reference substances include one or more of guanosine, 5-hydroxymethylfurfural, calycosin glucoside, formononetin, calycosin, astragalus and jujube.

8. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-retaining preparation according to claim 7, characterized in that: The dissolving agent is a methanol aqueous solution or water; optionally, in the methanol aqueous solution, the volume percentage of methanol is 5%-50%.

9. The method for constructing the characteristic spectrum of the Qi-invigorating and blood-replenishing preparation according to claim 1, characterized in that: The characteristic peaks of the characteristic spectrum of the Yiqiweixue preparation include 7 characteristic peaks, of which 5 characteristic peaks are identified: characteristic peak No. 3 is guanosine, characteristic peak No. 4 is 5-hydroxymethylfurfural, characteristic peak No. 5 is calycosin glucoside, characteristic peak No. 6 is formononetin, and characteristic peak No. 7 is calycosin.

10. Application of the characteristic spectrum of the Yiqi Weixue preparation constructed by the method for constructing the characteristic spectrum of the Yiqi Weixue preparation according to any one of claims 1 to 9 in the quality control of the Yiqi Weixue preparation.

Citation Information

Patent Citations

  • Method for establishing fusion-deduction fingerprint spectrum and application thereof in quality control of Yixuesheng capsule

    CN110274970A

  • Method for detecting fingerprint spectrum of Shengbai Koufuye

    CN112014481A

  • Method for determining specific chromatogram and content of angelica sinensis blood-replenishing compound preparation

    CN112394118A

  • Fingerprint spectrum detection method of Chinese angelica blood replenishing particle reference sample and fingerprint spectrum of Chinese angelica blood replenishing particle reference sample

    CN118294580A

  • Method for determining fingerprint of traditional chinese medicine composition

    WO2023024322A1